Clinical Trial Update: A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas [NA]

View source ↗

Summary

This entry reports a pilot study of rosiglitazone for GH-secreting pituitary adenomas. It provides limited information, with the trial status listed as UNKNOWN …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Pituitary Adenoma

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Zhaoyun Zhang | Conditions: Pituitary Tumor | NA | Status: UNKNOWN